Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Ligufalimab
Other

Ligufalimab

Tracked across 1 events · 33 articles · First seen May 25, 2026 · Last active Jun 08, 2026

Sentiment
60
Attention
7
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
7 60
Tech
ASCO 2026 Oncology Research Presentations
Impact: Ligufalimab is a novel therapeutic antibody from Akeso, a next-generation CD47 monoclonal antibody, also featured in presentations at ASCO 2026.
May 25, 2026 · 33 articles
ERGEN INTELLIGENCE
Track Ligufalimab live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.